Breaking News

Lonza, Moderna Expand COVID Vax Mfg. Alliance

Lonza to support the manufacture of up to an additional 300 million doses per year with install of a new manufacturing line at The Netherlands site.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Lonza expanded its collaboration with Moderna for the manufacture of the drug substance for Moderna’s COVID-19 Vaccine and provides for the installation of a new manufacturing line for drug substance production at Lonza’s Geleen (NL) site.   The new production line in Geleen will complement Lonza’s existing drug substance production network for the COVID-19 Vaccine and deliver a crucial manufacturing step to increase overall drug substance output. The new production line will contribute to the...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters